retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Eli Lilly's shows promising weight loss results in 3 New GLP-3 drug significantly slashes
Description
doi: 10.2337/db14-0849
An enzyme called dipeptidyl peptidase-4 (DPP-4) cleaves and inactivates GLP-1 almost instantly, preventing it from reaching therapeutic targets in any meaningful way
Obesity is linked to some of the most serious diseases in the developed world
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
GLP-1 Agonists What is it
[DOI] [PubMed] [Google Scholar] 129.GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives
